National Graphite Corp. announced that pursuant to the terms of the Exchange Agreement, at the Effective Time, Kenneth Liebscher, Howard Bouch and Fortunata Villamagna resigned as officers and directors of the company, and Ulrike Dickmann, Wolfgang Kochs and Martina Helmes were appointed as the directors of the company to serve until the earlier of their resignation or removal or until their respective successors are duly elected and qualified, as the case may be. Additionally, at the Effective Time Ulrike Dickmann was appointed as the President and Chief Executive Officer, Wolfgang Kochs was appointed as the Chief Financial Officer and Martina Helmes was appointed as the Secretary, of the Company.

Ulrike Dickmann is a Director and the President and CEO of the company and its wholly-owned subsidiary, Biotech Development Corp. Mrs. Dickmann has more 40 years of experience both in the field of health professions, as well as in the financial industry. Prior joining the company, Mrs. Dickmann was an independent investment advisor for qualified private investors in selected areas of Life Science and Healthcare.

Wolfgang Kochs is as a Director and CFO of the company and its wholly-owned subsidiary, Biotech Development Corp. Mr. Kochs has more than 40 years of experience in the financial industry. He was managing director and major shareholder of Kochs & Seidel, Boersenkommunikations GmbH., from 2003 to 1999, and prior to that was manager of Signature Equities GmbH, Dusseldorf and as the managing director of the RWV Loan Guarantee Bank GmbH.

Martina Helmes is a Director and the Secretary of the company and its subsidiary Biotech Development Corp. Mrs. Helmes has more than 25 years' experience in the field of the communication and customer service industry. Prior to Biotech Development Corp., Mrs. Helmes served as Managing Director of Life Science Future Technology PLC.